Ditemukan 1 dokumen yang sesuai dengan query
Ni Made Hustrini
"
Background: treatment of erythropoietin (EPO) is essential in chronic kidney disease (CKD) patients to maintain optimal hemoglobin (Hb) level. Renogen is a biosimilar epoetin-α, and Eprex is the originator epoetin-α. This study aimed to compare the efficacy and tolerance of Renogen with Eprex in CKD anemia.
Methods: Renogen and Eprex were compared in a randomized (2:1), open-label study for 8 weeks, proceeded by 4 weeks adjustment (maintenance) phase, in anemic CKD patients undergoing HD in Cipto ...
"
Jakarta: Faculty of Medicine University of Indonesia, 2019
610 UI-IJIM 51:3 (2019)
Artikel Jurnal Universitas Indonesia Library